The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 — Mount Arlington, New Jersey

The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 is a clinical research site located in Mount Arlington, New Jersey, United States 07856.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 has participated in 1 clinical trials.

Therapeutic areas: Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers.

Sponsors: APRINOIA Therapeutics, LLC.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204?

The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 conducted?

The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 has 1 clinical trials on record. Their work covers Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers.

Is The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 accredited by Crixeo Health?

The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The NeuroCognitive Institute (Site 103), 111 Howard Blvd., Suite 204?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.